![](/img/cover-not-exists.png)
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
Bourhis, J.-H., Bouko, Y., Koscielny, S., Bakkus, M., Greinix, H., Derigs, G., Salles, G., Feremans, W., Apperley, J., Samson, D., Bjorkstrand, B., Niederwieser, D., Gahrton, G., Pico, J.-L., GoldschmVolume:
92
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.10535
Date:
August, 2007
File:
PDF, 239 KB
english, 2007